-
公开(公告)号:US20230020272A1
公开(公告)日:2023-01-19
申请号:US17782734
申请日:2020-12-04
Applicant: NANEXA AB
Inventor: Anders JOHANSSON , Marten ROOTH , Joel HELLRUP
IPC: A61K9/50 , A61K31/706
Abstract: There is provided a process for the preparation of composition in the form of a plurality of particles having a weight-, number-, and/or volume-based mean diameter that is between amount 10 nm and about 700 μm, which particles comprise: (a) solid cores, preferably comprising a biologically active agent; and (b) two or more sequentially applied, discrete layers, each of which comprises at least one separately applied coating material, and which two or more layers together surround, enclose and/or encapsulate said cores, which process comprises the sequential steps of: (1) applying an initial layer of at least one coating material to said solid cores by way of a gas phase deposition technique; (2) discharging the coated particles from the gas phase deposition reactor and subjecting the coated particles to agitation to disaggregate particle aggregates formed during step (1) by way of mechanical sieving technique; (3) reintroducing the disaggregated, coated particles from step (2) into the gas phase deposition reactor and applying a further layer of at least one coating material to the reintroduced particles; and (1) optionally repeating steps (2) and (3) one or more times to increase the total thickness of the at least one coating material that enclose(s) said solid core. The gas phase deposition technique is preferably atomic layer deposition. When the cores comprise biologically active agent, the compositions may provide for the delayed or sustained release of said active agent without a burst effect.
-
公开(公告)号:US20160184484A1
公开(公告)日:2016-06-30
申请号:US14896849
申请日:2014-05-28
Applicant: NANEXA AB
Inventor: Anders JOHANSSON , Marten ROOTH , Jan-Otto CARLSSON
CPC classification number: A61L29/106 , A61L29/14 , A61L29/143 , A61L29/16 , A61L2300/10 , A61L2300/404 , A61L2400/10 , A61L2420/02 , A61M25/0009 , A61M25/0045 , A61M2025/0046 , A61M2025/0062 , B05D5/08 , C09D7/20 , C10M103/00 , C10M111/02 , C10M2201/0873 , C10N2230/06 , C10N2240/66 , C10N2250/121
Abstract: The present invention relates to a method of forming a boric acid coating on a substrate surface and a vein catheter comprising said coating.
Abstract translation: 本发明涉及在基材表面上形成硼酸涂层的方法和包括所述涂层的静脉导管。
-
公开(公告)号:US20180221294A1
公开(公告)日:2018-08-09
申请号:US15944059
申请日:2018-04-03
Applicant: Nanexa AB
Inventor: Jan-Otto CARLSSON , Anders JOHANSSON , Marten ROOTH
CPC classification number: A61K9/5192 , A61K9/5073 , A61K9/5115
Abstract: A nanoparticle having a solid core comprising a biologically active substance, said core being enclosed by an inorganic coating, a method for preparing the nanoparticle, and the use of the nanoparticle in therapy. A kit comprising the nanoparticle and a pharmaceutical composition comprising the nanoparticle.
-
公开(公告)号:US20180085321A1
公开(公告)日:2018-03-29
申请号:US15645073
申请日:2017-07-10
Applicant: Nanexa AB
Inventor: Jan-Otto CARLSSON , Anders JOHANSSON , Marten ROOTH
CPC classification number: A61K9/5192 , A61K9/5073 , A61K9/5115
Abstract: A nanoparticle having a solid core comprising a biologically active substance, said core being enclosed by an inorganic coating, a method for preparing the nanoparticle, and the use of the nanoparticle in therapy. A kit comprising the nanoparticle and a pharmaceutical composition comprising the nanoparticle.
-
公开(公告)号:US20160081945A1
公开(公告)日:2016-03-24
申请号:US14891398
申请日:2014-05-23
Applicant: NANEXA AB
Inventor: Jan-Otto CARLSSON , Anders JOHANSSON , Marten ROOTH
IPC: A61K9/51
CPC classification number: A61K9/5192 , A61K9/5073 , A61K9/5115
Abstract: A nanoparticle having a solid core comprising a biologically active substance, said core being enclosed by an inorganic coating, a method for preparing the nanoparticle, and the use of the nanoparticle in therapy. A kit comprising the nanoparticle and a pharmaceutical composition comprising the nanoparticle.
Abstract translation: 具有包含生物活性物质的固体核的纳米颗粒,所述核被无机涂层包围,制备纳米颗粒的方法以及纳米颗粒在治疗中的用途。 包含纳米颗粒的试剂盒和包含纳米颗粒的药物组合物。
-
-
-
-